Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats.
about
The therapeutic profile of rolipram, PDE target and mechanism of action as a neuroprotectant following spinal cord injuryPosttraumatic therapeutic vaccination with modified myelin self-antigen prevents complete paralysis while avoiding autoimmune diseaseCytokine responses during chronic denervation.Methylprednisolone in the management of spinal cord injuries: Lessons from randomized, controlled trialsTherapeutic Hypothermia in Spinal Cord Injury: The Status of Its Use and Open QuestionsSpinal interleukin-10 therapy to treat peripheral neuropathic painEphB3 receptors function as dependence receptors to mediate oligodendrocyte cell death following contusive spinal cord injuryGlial tumor necrosis factor alpha (TNFα) generates metaplastic inhibition of spinal learningReciprocal modulation between microglia and astrocyte in reactive gliosis following the CNS injuryCombination therapies for neurobehavioral and cognitive recovery after experimental traumatic brain injury: Is more better?Temperature- and time-dependent changes in TLR2-activated microglial NF-κB activity and concentrations of inflammatory and anti-inflammatory factorsIdentification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cordAge decreases macrophage IL-10 expression: Implications for functional recovery and tissue repair in spinal cord injuryGenetic Ablation of Soluble TNF Does Not Affect Lesion Size and Functional Recovery after Moderate Spinal Cord Injury in Mice.Monocyte recruitment and myelin removal are delayed following spinal cord injury in mice with CCR2 chemokine receptor deletion.IL-10 within the CNS is necessary for CD4+ T cells to mediate neuroprotectionPEGylated interferon-beta modulates the acute inflammatory response and recovery when combined with forced exercise following cervical spinal contusion injury.Transgenic inhibition of astroglial NF-kappa B leads to increased axonal sparing and sprouting following spinal cord injury.Vaccination with a Nogo-A-derived peptide after incomplete spinal-cord injury promotes recovery via a T-cell-mediated neuroprotective response: comparison with other myelin antigensEfficacy of some non-conventional herbal medications (sulforaphane, tanshinone IIA, and tetramethylpyrazine) in inducing neuroprotection in comparison with interleukin-10 after spinal cord injury: A meta-analysis.System x(c)(-) regulates microglia and macrophage glutamate excitotoxicity in vivoRole of microglia in neurotrauma.The effect of mesenchymal stem cell transplantation on the recovery of bladder and hindlimb function after spinal cord contusion in rats.Central but not systemic administration of XPro1595 is therapeutic following moderate spinal cord injury in miceA toll-like receptor 9 antagonist improves bladder function and white matter sparing in spinal cord injury.The p38alpha mitogen-activated protein kinase limits the CNS proinflammatory cytokine response to systemic lipopolysaccharide, potentially through an IL-10 dependent mechanismThe spinal cord research foundation: two decades of progress.Under one roof: the Miami Project to Cure Paralysis model for spinal cord injury research.Circulating endotoxin and systemic immune activation in sporadic amyotrophic lateral sclerosis (sALS).Role of the immune system in chronic pain.The biochemical origin of pain--proposing a new law of pain: the origin of all pain is inflammation and the inflammatory response. Part 1 of 3--a unifying law of painRecent advances in pathophysiology and treatment of spinal cord injury.Early-stage treatment with Withaferin A reduces levels of misfolded superoxide dismutase 1 and extends lifespan in a mouse model of amyotrophic lateral sclerosis.Effects of tumor necrosis factor alpha blocker adalimumab in experimental spinal cord injury.Post-traumatic inflammation following spinal cord injury.Reduced inflammatory phenotype in microglia derived from neonatal rat spinal cord versus brainEstrogen alters baseline and inflammatory-induced cytokine levels independent from hypothalamic-pituitary-adrenal axis activityProinflammatory cytokine regulation of cyclic AMP-phosphodiesterase 4 signaling in microglia in vitro and following CNS injury.Fas/FasL-mediated apoptosis and inflammation are key features of acute human spinal cord injury: implications for translational, clinical application.Effects of Olig2-overexpressing neural stem cells and myelin basic protein-activated T cells on recovery from spinal cord injury
P2860
Q21089854-3C43696A-438A-4C36-B460-1B4C8AD188DBQ24671661-045D8E17-6E7C-4FCF-9325-312B8B096221Q24815947-8081BC82-8EC6-4523-8F94-49A769557FE4Q26782453-04FEAC43-9C5C-4CB5-A5BF-08AD47CB8CAEQ26799349-E38D8F7F-16A6-4DAE-B73D-64113AA57EC6Q26861391-F1F8D0E5-45AE-4255-8B2D-C25E8610AA54Q27329888-948071E8-264B-4CF7-891E-DEC68533AD6EQ28385590-3F982ADC-BA19-41E2-92A9-10984FC044CCQ28389274-2C1FADE7-BEB5-4D1D-9A11-74998CD6C9D7Q28397361-1626DA8F-E7FB-42EF-AEA7-FBF570EB3EBCQ28574474-3C66A1A8-446E-44AE-BD03-73F55141FF4DQ29619388-61EA6001-4868-4736-8EE7-A39A6F709F25Q30676865-9C1A3366-71EF-4768-9BFD-AD53495085BDQ30833318-E2F5C22F-EE9F-4EBE-812B-0661349163F2Q31096336-B94E8BCA-95FF-4588-B696-6622CFFFE5BDQ33665740-89507762-EF4F-48F6-9266-455B58E949CCQ33829033-76B88DAC-2831-4D77-B8FB-6F4CB7E6029CQ33874697-50492227-618B-40FE-92C8-C1D729C82AFDQ33953007-69C5EE73-AD1C-4956-BEFB-6A88140515E5Q34041359-CFA0E5C0-5EF0-465E-A34D-4C5C5C323C28Q34073426-77BCE092-311A-45D6-891A-D1CBA7D87B48Q34168279-1A9123CC-9A0F-4B2D-822E-E8BDA384474EQ34199629-85911FAC-3F69-4EF5-A6FE-C0F1D768EF31Q34250544-4B4EA7F1-DD3B-47AC-B29D-53E13F84568CQ34293455-4DBEE43D-2822-430F-A54B-78806C2A339EQ34324047-9BE35812-D8EC-406C-A89A-AC89DE50FB01Q34331920-7CEB9A23-6810-44CC-B342-F234A7656DC0Q34333338-560D7FAD-2232-40A9-9166-CDD931E87790Q34369439-99AB7A58-9B43-4D4F-94EC-FD6C01B806BEQ34431134-CA664C9F-1F0F-4DAA-A53D-779DF66CCC6BQ34604663-A52FFBDA-F238-45EB-9D7B-58DB99869540Q35005402-F672C99B-481F-43E2-AD84-6B261C715746Q35064952-E8CD280E-ACBB-4E4E-B055-CCB35B259FEAQ35133588-43C42240-F2F5-4E0C-8CCF-6420A9E34E09Q35157997-F945695F-B126-49C2-A8FC-48C592480572Q35184712-73083927-3F4B-4301-80F3-F9A3B1C946C5Q35195146-C636D034-D0DF-4E06-BB47-DBD0407E4489Q35249097-9EF067E1-CF16-46EF-AE37-F53C3ADBCCABQ35574725-31717E40-5297-4FAA-B89F-D36F81BF80D3Q35913786-BC481C03-23EB-43B2-8E09-241D4689F332
P2860
Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Systemically administered inte ...... ic spinal cord injury in rats.
@en
Systemically administered inte ...... ic spinal cord injury in rats.
@nl
type
label
Systemically administered inte ...... ic spinal cord injury in rats.
@en
Systemically administered inte ...... ic spinal cord injury in rats.
@nl
prefLabel
Systemically administered inte ...... ic spinal cord injury in rats.
@en
Systemically administered inte ...... ic spinal cord injury in rats.
@nl
P2093
P356
P1476
Systemically administered inte ...... ic spinal cord injury in rats.
@en
P2093
Dietrich WD
Marcillo AE
Nagashima H
P304
P356
10.1089/NEU.1999.16.851
P577
1999-10-01T00:00:00Z